DIFFRACTION OF BACTERIAL ENDOTOXINS: STRUCT BASED DRUG DESIGN, SCREEN PCP ENZYME
细菌内毒素的衍射:基于结构的药物设计,筛选 PCP 酶
基本信息
- 批准号:6491104
- 负责人:
- 金额:$ 14.27万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2001
- 资助国家:美国
- 起止时间:2001-08-15 至 2002-08-14
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Delta endotoxins are the entomocidal agent produced by Bacillus
thuringiensis ssp. Kurstaki. These toxins are produced as protoxins
(135 kDa) by the bacteria during sporulation and recognized by their
bipyrimidal crystalline form in the sporangium. When ingested by
larval Lepidoptera the crystal dissolves and is proteolytically
digested to the active toxin form (60-65 kDa). This activated toxin
is capable of opening K+ channels in the epithelium of the insect
midgut. Ion leakage ultimately results in the complete disruption of
the midgut and death of the insect. More recently, a new active form
of the toxin, CryIIIB2, has been determined (64 kDa). The bacterial
endotoxin CryIIIB2 is a 652 residue protein which crystallizes in the
orthorhombic space group C2221 with unit cell dimensions a = 122.44, b
= 131.81, and c = 105.37& and contain one molecule in the asymmetric
unit. Synchrontron radiation was used to collect 2.2& resolution data
at the CHESS facility at Cornell University in December, 1997 by
Vivian Cody and Nikolai Galitsky for the complex of EC11095 with
D-galactosamine. Although these data were did not diffract uniformly
to high resolution, Walt Pangborn was able to scale data with at least
50% completion for all shells to 2.2& resolution. The structure of
the native CryIIIB2 was used as a search model for the rotation and
translation function in the program XPLOR which revealed there was no
significant change in the molecular orientation of the molecule
compared to the room temperature model. The major consequence of low
temperature data collection is the contraction of the unit cell along
the a and b lattice directions. Interpretation of the difference
electron density maps made from the 3.0& refinement model of the
Arg-348 mutant of CryIIIB2 revealed a large density profile that
clearly was not a cluster of solvent and that could be fit to the
sugar. These data reveal that the galactosamine is positioned at the
intersection of the three domains of CryIIIB2. Refinement of these
data to 2.2& resolution suggest other potential sugar binding sites
are possible.
δ内毒素是芽孢杆菌产生的杀虫剂
苏云金杆菌亚种 库斯塔基 这些毒素以原毒素的形式产生
(135 kDa),并通过它们的
孢子囊中的双嘧啶晶体形式。 当摄入
鳞翅目幼虫晶体溶解并被蛋白水解
消化成活性毒素形式(60-65 kDa)。 这种激活的毒素
能够打开昆虫上皮中的K+通道
中肠 离子泄漏最终导致
昆虫的中肠和死亡 最近,一种新的活性形式
毒素CryIIIB 2的分子量为64 kDa。 细菌
内毒素CryIIIB 2是一种652个残基的蛋白质,
正交晶系空间群C2221,晶胞维数a = 122.44,B
= 131.81,c = 105.37,并且含有一个不对称分子
单位 采用同步辐射技术采集了2.2级分辨率的数据
1997年12月在康奈尔大学的国际象棋设施,
Vivian Cody和Nikolai Galitsky为EC 11095的复合体设计,
D-半乳糖胺 虽然这些数据并不一致,
到高分辨率,Walt Pangborn能够至少以
50%完成所有外壳到2.2和分辨率。 的结构
天然CryIIIB 2用作旋转的搜索模型,
翻译功能的程序XPLOR,其中显示没有
分子取向的显著变化
与室温模型相比。 低的主要后果
温度数据收集是单位单元沿着的收缩
a和B晶格方向。 差异的解释
电子密度图由3.0&细化模型的
CryIIIB 2的Arg-348突变体显示了大的密度分布,
显然不是一种溶剂,它可以适合
糖 这些数据表明,半乳糖胺位于
CryIIIB 2的三个结构域的交叉。 改进这些
2.2和分辨率的数据表明其他潜在的糖结合位点
是可能的。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Vivian Cody其他文献
Vivian Cody的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Vivian Cody', 18)}}的其他基金
STRUCTURAL STUDIES OF AIDS-RELATED ENZYMES AND OTHER PATHOGENIC TARGETS
艾滋病相关酶和其他致病靶标的结构研究
- 批准号:
8362410 - 财政年份:2011
- 资助金额:
$ 14.27万 - 项目类别:
PROTEIN-PROTEIN INTERACTIONS OF DIHYDROFOLATE REDUCTASE
二氢叶酸还原酶的蛋白质-蛋白质相互作用
- 批准号:
6977201 - 财政年份:2004
- 资助金额:
$ 14.27万 - 项目类别:
DIFFRACTION OF BACTERIAL ENDOTOXINS: STRUCT BASED DRUG DESIGN, SCREEN PCP ENZYME
细菌内毒素的衍射:基于结构的药物设计,筛选 PCP 酶
- 批准号:
6667781 - 财政年份:2002
- 资助金额:
$ 14.27万 - 项目类别:
DIFFRACTION OF BACTERIAL ENDOTOXINS: STRUCT BASED DRUG DESIGN, SCREEN PCP ENZYME
细菌内毒素的衍射:基于结构的药物设计,筛选 PCP 酶
- 批准号:
6339116 - 财政年份:2000
- 资助金额:
$ 14.27万 - 项目类别:
DIFFRACTION OF BACTERIAL ENDOTOXINS: STRUCT BASED DRUG DESIGN, SCREEN PCP ENZYME
细菌内毒素的衍射:基于结构的药物设计,筛选 PCP 酶
- 批准号:
6220476 - 财政年份:1999
- 资助金额:
$ 14.27万 - 项目类别:
相似海外基金
Collaboration in Regulatory Systems Strengthening and Standardization Activities to Increase Global Access to Safe and Effective Biological Products.
加强监管系统和标准化活动方面的合作,以增加全球获得安全有效的生物产品的机会。
- 批准号:
10448926 - 财政年份:2021
- 资助金额:
$ 14.27万 - 项目类别:
Collaboration in Regulatory Systems Strengthening and Standardization Activities to Increase Global Access to Safe and Effective Biological Products.
加强监管系统和标准化活动方面的合作,以增加全球获得安全有效的生物产品的机会。
- 批准号:
10491861 - 财政年份:2021
- 资助金额:
$ 14.27万 - 项目类别:
Collaboration in Regulatory Systems Strengthening and Standardization Activities to Increase Global Access to Safe and Effective Biological Products.
加强监管系统和标准化活动方面的合作,以增加全球获得安全有效的生物产品的机会。
- 批准号:
10675535 - 财政年份:2021
- 资助金额:
$ 14.27万 - 项目类别:
EPSRC Centre for Doctoral Training in Bioprocess Engineering Leadership (Complex Biological Products Manufacture)
EPSRC 生物过程工程领导力博士培训中心(复杂生物制品制造)
- 批准号:
EP/S021868/1 - 财政年份:2019
- 资助金额:
$ 14.27万 - 项目类别:
Training Grant
Exploring interactions and benefits of novel microbial biological products in blueberry propagation
探索新型微生物生物制品在蓝莓繁殖中的相互作用和益处
- 批准号:
529840-2018 - 财政年份:2018
- 资助金额:
$ 14.27万 - 项目类别:
Applied Research and Development Grants - Level 1
GOALI: Collaborative Research: Industrial Implementation of Smart Biopolymers for Purification of Biological Products
目标:合作研究:用于生物制品纯化的智能生物聚合物的工业实施
- 批准号:
1403724 - 财政年份:2014
- 资助金额:
$ 14.27万 - 项目类别:
Standard Grant
GOALI: Collaborative Research: Industrial Implementation of Smart Biopolymers for Purification of Biological Products
目标:合作研究:用于生物制品纯化的智能生物聚合物的工业实施
- 批准号:
1403697 - 财政年份:2014
- 资助金额:
$ 14.27万 - 项目类别:
Standard Grant
Formulation and delivery approaches for water soluble biological products delivered through the skin focussing on L-Ascorbic Acid.
通过皮肤输送的水溶性生物产品的配方和输送方法,重点是 L-抗坏血酸。
- 批准号:
131690 - 财政年份:2014
- 资助金额:
$ 14.27万 - 项目类别:
Feasibility Studies
Formulation and stability of biological products for skin delivery focussing on Retinol.
以视黄醇为重点的皮肤输送生物制品的配方和稳定性。
- 批准号:
131338 - 财政年份:2013
- 资助金额:
$ 14.27万 - 项目类别:
Feasibility Studies
Demonstrate the effectiveness of antimicrobial protection of new types of Biological Products
展示新型生物制品抗菌保护的有效性
- 批准号:
429734-2011 - 财政年份:2012
- 资助金额:
$ 14.27万 - 项目类别:
Experience Awards (previously Industrial Undergraduate Student Research Awards)














{{item.name}}会员




